You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 269 No. 10, March 10, 1993 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Periconceptional Folic Acid Exposure and Risk of Occurrent Neural Tube Defects

Martha M. Werler, ScD; Samuel Shapiro, MB, FRCPE; Allen A. Mitchell, MD

JAMA. 1993;269(10):1257-1261.


Abstract

Objectives.
—A recent controlled trial has established that use of a 4-mg folic acid supplement before and during early pregnancy reduces the risk of recurrent neural tube defects (NTDs) by 72%. The present study was designed to determine whether folic acid also reduces the risk of first (occurrent) NTDs.

Design.
—Case-control study.

Setting.
—Tertiary and birth hospitals in metropolitan areas of Boston, Mass, Philadelphia, Pa, and Toronto, Ontario.

Participants.
—Mothers of 436 occurrent cases with NTDs and mothers of 2615 controls with other major malformations.

Main Outcome Measures.
—The prevalence of use of multivitamins containing folic acid was compared between mothers of cases and controls.

Results.
—The mothers of 17% of cases and 3% of controls reported knowledge of the folic acid—NTD hypothesis and were excluded from further analysis. For daily use of multivitamins containing folic acid in the periconceptional period (28 days before through 28 days after the last menstrual period), the relative risk (RR) (and 95% confidence interval) was 0.4 (0.2 to 0.6). The most commonly used dose of folic acid was 0.4 mg, and the RR estimate was 0.3 (95% confidence interval, 0.1 to 0.6). For dietary folate, there was a dose-related decline in risk according to the quintile of intake (P for trend=.02).

Conclusion.
—These findings suggest that daily periconceptional intake of 0.4 mg of folic acid (the dose most commonly contained in over-the-counter multivitamin preparations) reduces the risk of occurrent NTDs by approximately 60%. A relatively high dietary intake of folate may also reduce the risk.

(JAMA. 1993;269:1257-1261)



Author Affiliations

From the Slone Epidemiology Unit, Boston University School of Medicine, Brookline, Mass.


Footnotes

Presented in part at the New York Academy of Sciences meeting, Maternal Nutrition and Pregnancy Outcome, San Diego, Calif, May 19, 1992, and the Centers for Disease Control and Prevention, Atlanta, Ga, July 27, 1992.

Reprint requests to Slone Epidemiology Unit, Boston University School of Medicine, 1371 Beacon St, Brookline, MA 02146 (Dr Werler).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neural Tube Defects and Maternal Folate Intake Among Pregnancies Conceived After Folic Acid Fortification in the United States
Mosley et al.
Am J Epidemiol 2009;169:9-17.
ABSTRACT | FULL TEXT  

Invited Commentary: Preventing Neural Tube Defects and More via Food Fortification?
Mills and Carter
Am J Epidemiol 2009;169:18-21.
ABSTRACT | FULL TEXT  

Wheat Flour Fortification Is Unlikely to Benefit the Neediest in Guatemala
Imhoff-Kunsch et al.
J. Nutr. 2007;137:1017-1022.
ABSTRACT | FULL TEXT  

Folate and neural tube defects
Pitkin
Am. J. Clin. Nutr. 2007;85:285S-288S.
ABSTRACT | FULL TEXT  

Folate and human reproduction
Tamura and Picciano
Am. J. Clin. Nutr. 2006;83:993-1016.
ABSTRACT | FULL TEXT  

Survival of Infants With Neural Tube Defects in the Presence of Folic Acid Fortification
Bol et al.
Pediatrics 2006;117:803-813.
ABSTRACT | FULL TEXT  

Describing a Folic Acid Intervention for Health Care Providers: Implications for Professional Practice and Continuing Education
Helinski et al.
Health Promot Pract 2004;5:326-333.
ABSTRACT  

Fumonisins Disrupt Sphingolipid Metabolism, Folate Transport, and Neural Tube Development in Embryo Culture and In Vivo: A Potential Risk Factor for Human Neural Tube Defects among Populations Consuming Fumonisin-Contaminated Maize
Marasas et al.
J. Nutr. 2004;134:711-716.
ABSTRACT | FULL TEXT  

Neural Tube Defects: Knowledge and Preconceptional Prevention Practices in Minority Young Women
Chacko et al.
Pediatrics 2003;112:536-542.
ABSTRACT | FULL TEXT  

Management issues for women with epilepsy: Neural tube defects and folic acid supplementation
Yerby
Neurology 2003;61:S23-26.
ABSTRACT | FULL TEXT  

Fetal Therapy: State of the Art
Coleman et al.
J Ultrasound Med 2002;21:1257-1288.
ABSTRACT | FULL TEXT  

Increases in Blood Folate Indices Are Similar in Women of Childbearing Age Supplemented with [6S]-5-Methyltetrahydrofolate and Folic Acid
Venn et al.
J. Nutr. 2002;132:3353-3355.
ABSTRACT | FULL TEXT  

Neural tube defects and periconceptional folic acid
Kadir and Economides
CMAJ 2002;167:255-256.
FULL TEXT  

Vitamins for Chronic Disease Prevention in Adults: Scientific Review
Fairfield and Fletcher
JAMA 2002;287:3116-3126.
ABSTRACT | FULL TEXT  

Anaphylactic shock secondary to intravenous administration of folinic acid: a first report
Benchalal et al.
Ann Oncol 2002;13:480-481.
ABSTRACT | FULL TEXT  

Causal Knowledge as a Prerequisite for Confounding Evaluation: An Application to Birth Defects Epidemiology
Hernan et al.
Am J Epidemiol 2002;155:176-184.
ABSTRACT | FULL TEXT  

Application of the Method of Triads to Evaluate the Performance of Food Frequency Questionnaires and Biomarkers as Indicators of Long-term Dietary Intake
Kabagambe et al.
Am J Epidemiol 2001;154:1126-1135.
ABSTRACT | FULL TEXT  

Expression of the reduced folate carrier SLC19A1 in IEC-6 cells results in two distinct transport activities
Rajgopal et al.
Am. J. Physiol. Cell Physiol. 2001;281:C1579-C1586.
ABSTRACT | FULL TEXT  

Neural Tube Defects in Relation to Use of Folic Acid Antagonists during Pregnancy
Hernandez-Diaz et al.
Am J Epidemiol 2001;153:961-968.
ABSTRACT | FULL TEXT  

Folate, Homocysteine and Neural Tube Defects: An Overview
van der Put et al.
Exp. Biol. Med. 2001;226:243-270.
ABSTRACT | FULL TEXT  

Folate Status during Pregnancy in Women Is Improved by Long-term High Vegetable Intake Compared with the Average Western Diet
Koebnick et al.
J. Nutr. 2001;131:733-739.
ABSTRACT | FULL TEXT  

Maternal Exposure to Nitrate from Drinking Water and Diet and Risk for Neural Tube Defects
Croen et al.
Am J Epidemiol 2001;153:325-331.
ABSTRACT | FULL TEXT  

Adaptive regulation of intestinal folate uptake: effect of dietary folate deficiency
Said et al.
Am. J. Physiol. Cell Physiol. 2000;279:C1889-C1895.
ABSTRACT | FULL TEXT  

Neural Tube Defects among Mexican Americans Living on the US-Mexico Border: Effects of Folic Acid and Dietary Folate
Suarez et al.
Am J Epidemiol 2000;152:1017-1023.
ABSTRACT | FULL TEXT  

Folate absorption in women with a history of neural tube defect-affected pregnancy
Boddie et al.
Am. J. Clin. Nutr. 2000;72:154-158.
ABSTRACT | FULL TEXT  

Folate and vitamin B12 status of women in Newfoundland at their first prenatal visit
CMAJ 2000;162:1557-1559.
 

Neural-Tube Defects
Schulman et al.
NEJM 2000;342:1135-1137.
FULL TEXT  

Prevention of Neural-Tube Defects with Folic Acid in China
Berry et al.
NEJM 1999;341:1485-1490.
ABSTRACT | FULL TEXT  

Neural-Tube Defects
Botto et al.
NEJM 1999;341:1509-1519.
FULL TEXT  

Folic Acid Supplementation of Pregnant Mice Suppresses Heat-Induced Neural Tube Defects in the Offspring
Shin and Shiota
J. Nutr. 1999;129:2070-2073.
ABSTRACT | FULL TEXT  

The Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine Concentrations
Jacques et al.
NEJM 1999;340:1449-1454.
ABSTRACT | FULL TEXT  

Absorption of Dietary and Supplemental Folate in Women with Prior Pregnancies with Neural Tube Defects and Controls
Neuhouser et al.
J. Am. Coll. Nutr. 1998;17:625-630.
ABSTRACT | FULL TEXT  

A Three-Day Weighed Food Record and a Semiquantitative Food-Frequency Questionnaire Are Valid Measures for Assessing the Folate and Vitamin B-12 Intakes of Women Aged 16 to 19 Years
Green et al.
J. Nutr. 1998;128:1665-1671.
ABSTRACT | FULL TEXT  

Total Parenteral Nutrition During Pregnancy in a Patient Requiring Long-Term Nutrition Support
Mamel et al.
Nutr Clin Pract 1998;13:123-128.
ABSTRACT  

Drugs in Pregnancy
Koren et al.
NEJM 1998;338:1128-1137.
FULL TEXT  

Neural Tube and Craniofacial Defects With Special Emphasis On Folate Pathway Genes
Finnell et al.
CROBM 1998;9:38-53.
ABSTRACT | FULL TEXT  

Predictors of Red Cell Folate Level in Women Attempting Pregnancy
Brown et al.
JAMA 1997;277:548-552.
ABSTRACT  

Prepregnant Weight in Relation to Risk of Neural Tube Defects
Werler et al.
JAMA 1996;275:1089-1092.
ABSTRACT  

Analysis of the vestigial tail mutation demonstrates that Wnt-3a gene dosage regulates mouse axial development.
Greco et al.
Genes Dev. 1996;10:313-324.
ABSTRACT  

Folate Levels and Neural Tube Defects: Implications for Prevention
Daly et al.
JAMA 1995;274:1698-1702.
ABSTRACT  

Preconceptional Counseling and Intervention
Kuller and Laifer
Arch Intern Med 1994;154:2273-2280.
ABSTRACT  

Nutrition
Russell
JAMA 1994;271:1687-1689.
ABSTRACT  

Review Article : The Yolk Sac Theory: Closing the Circle on Why Diabetes-Associated Malformations Occur
Reece et al.
Reproductive Sciences 1994;1:3-13.
ABSTRACT  

Nutrition
Russell
JAMA 1993;270:233-234.
ABSTRACT  

MORE SUPPORT FOR FOLIC ACID TO PREVENT NEURAL TUBE DEFECTS
JWatch General 1993;1993:4-4.
FULL TEXT  

Folic Acid-Preventable Spina Bifida and Anencephaly
Oakley
JAMA 1993;269:1292-1293.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.